Abstract:Antimicrobial resistance (AMR) poses a significant global health threat, necessitating the development of novel antibacterial strategies. Serratiopeptidase (SP), a metalloprotease produced by bacteria such as Serratia marcescens, has gained attention not only for its anti-inflammatory properties but also for its potential antibacterial activity. However, its protein nature makes it susceptible to pH changes and self-proteolysis, limiting its effectiveness. This study aimed to increase both the enzymatic stability and antibacterial activity of serratiopeptidase through immobilization on titanium oxide nanoparticles (TiO2-NPs), leveraging the biocompatibility and stability of these nanomaterials. Commercial TiO2-NPs were characterized using TGA/DTG, FT-IR, UV-Vis, and XRD analyses, and their biocompatibility was assessed through cytotoxicity studies. Serratiopeptidase was produced via fermentation using the C8 isolate of Serratia marcescens obtained from the intestine of Bombyx mori L., purified chromatographically, and immobilized on carboxylated nanoparticles via EDC/NHS coupling at various pH conditions. The optimal enzymatic activity was achieved by using pH 5.1 for nanoparticle activation and pH 5.5 for enzyme coupling. The resulting bioconjugate demonstrated stable proteolytic activity at 25 °C for 48 h. Immobilization was confirmed by FT-IR spectroscopy, and the Michaelis-Menten kinetics were determined. Notably, the bioconjugate exhibited two-fold greater antibacterial activity against E. coli than the free enzyme or TiO2-NPs at 1000 µg/mL. This study successfully developed a serratiopeptidase-TiO2 bioconjugate with enhanced enzymatic stability and antibacterial properties. The improved antibacterial activity of the immobilized enzyme presents a promising approach for developing new tools to combat antimicrobial resistance, with potential applications in healthcare, food safety, and environmental protection.

Site‐Specific Conjugation of a Selenopolypeptide to Alpha‐1‐antitrypsin Enhances Oxidation Resistance and Pharmacological Properties

Oxidation‐resistant and Thermostable Forms of Alpha‐1 Antitrypsin from Escherichia Coli Inclusion Bodies

A Novel Zwitterionic Copolymer with A Short Poly(Methyl Acrylic Acid) Block for Improving Both Conjugation and Separation Efficiency of A Protein Without Losing Its Bioactivity

Site-specific Enzymatic Polysialylation of Therapeutic Proteins Using Bacterial Enzymes

Clickable,Oxidation-Responsive and Enzyme-Degradable Polypeptide:Synthesis,Characterization and Side Chain Modification

Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential

Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency

Generation of therapeutic protein variants with the human serum albumin binding capacity via site-specific fatty acid conjugation

Evaluation of cytosine base editing and adenine base editing as a potential treatment for alpha-1 antitrypsin deficiency

Glycoengineered recombinant alpha1-antitrypsin results in comparable and activities to human plasma-derived protein

A Novel Selenium and Copper-containing Peptide with Both Superoxide Dismutase and Glutathione Peroxidase Activities

Protection of Mitochondrial Integrity from Oxidative Stress by Selenium-Containing Glutathione Transferase

Study on the Properties and Synergistic Antioxidant Effects of Novel Bifunctional Fusion Proteins Expressed Using the UTuT6 System.

Sulfatase-Induced in Situ Formulation of Antineoplastic Supra-PROTACs

Biosynthesis of Selenosubtilisin: A Novel Way to Target Selenium into the Active Site of Subtilisin

Gene Manipulation Based Selenium-Containing Peptide Exhibiting Synergism of Sod and Gpx

Combating Atherosclerosis with Chirality/Phase Dual‐Engineered Nanozyme Featuring Microenvironment‐Programmed Senolytic and Senomorphic Actions

PEGylation of the Antimicrobial Peptide PG-1: A Link Between Propensity for Nanostructuring and Capacity of the Antitrypsin Hydrolytic Ability.

Ultrasmall Ruthenium Nanoparticles with Boosted Antioxidant Activity Upregulate Regulatory T Cells for Highly Efficient Liver Injury Therapy

Bioconjugation of Serratiopeptidase with Titanium Oxide Nanoparticles: Improving Stability and Antibacterial Properties

Molecular Mechanism of Z Α1-Antitrypsin Deficiency